Analytical solutions from SCIEX help enable drug discovery, development, and QC for gene therapeutics, oligonucleotides, protein-based biologics, next-generation vaccines, and traditional small molecule drugs. Our industry-leading LC-MS, LC-MS/MS and CE solutions reduce complexity across the entire process – from metabolite identification in small molecule drug candidates to biotransformations in biologics, as well as characterization in discovery, analytical development and QC. Whether you want to optimize your lab’s current capabilities or scale-up to meet your future demands, SCIEX aims to make you more productive with end-to-end CE and LC-MS solutions.